share_log

Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $17

Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $17

Canaccord Genuity維持對Core Scientific的買入評級,並將價格目標上調至17美元
Benzinga ·  10/23 06:39  · 評級/大行評級

Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and raises the price target from $16 to $17.

Canaccord Genuity分析師Joseph Vafi維持對Core Scientific(納斯達克:CORZ)的買入評級,並將價格目標從16美元提高到17美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論